Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Online Resource Helps Manage Patients on Anticoagulant Therapy

By LabMedica International staff writers
Posted on 17 Nov 2010
An online resource helps simplify and streamline the process of managing patients on anticoagulation therapy.

The web-based application gives patients who self-test their prothrombin time/international normalized ratio (PT/INR or clotting time) a simple, convenient way to report their test results and gives doctors a single, secure site to access data to more effectively monitor and manage their patients on warfarin therapy.

It is available to physicians who prescribe a patient self-testing program through CoaguChek Patient Services (CPS), an Independent Diagnostic Testing Facility (IDTF) that provides support services for physicians and their patients.

CoaguChek Link offers healthcare providers a convenient patient management resource, helping to simplify documentation and streamline office workflow so they can focus on patients that require follow-up care. More...
Clinics and physician offices can use the application to quickly enroll patients with CPS, educate them about their therapy, view test results in real time through a password-protected portal, modify recommended test frequency or acceptable ranges for patient test results, and generally, access the information needed to monitor and adjust a patient's anticoagulant therapy from anywhere.

The patient portal of CoaguChek Link helps patients to take a more active role in their anticoagulation therapy. At their convenience, enrolled patients can simply log in to the site to report their test results, order supplies, update their profile information, or learn more about their own therapy and the importance of testing.

Roche Diagnostics (Indianapolis, IN, USA) introduced the CoaguChek link web resource, which was developed in conjunction with Voluntis (Suresnes, France) a healthcare software company specializing in Patient Relationship Management. The application is based on Voluntis' MedPassport platform.

"CoaguChek Link helps doctors and their patients stay connected so they can work together to manage the patient's anticoagulation therapy more effectively, whether the patient is at home or away," said Tim Huston, director of marketing, professional diagnostics at Roche Diagnostics Corporation. "It simplifies the process for everyone, facilitates better therapy management, and contributes to the goal of helping improve patient outcomes."

Related Links:

CoaguChek
Roche Diagnostics
Voluntis


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.